Role of fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of head and neck carcinoma
Fluorodeoxyglucose (FDG)-positron emission tomography-computed tomography (PET-CT) has been playing a pivotal role in tumor imaging for the past 20 years. Head and neck (HN) cancers are a good example that can illustrate such unique role of FDG imaging contributing to the patient's management....
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2017-10-01
|
| Series: | World Journal of Nuclear Medicine |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_40_17 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849324730725695488 |
|---|---|
| author | Moheieldin Abouzied Ahmed Fathala Abdulaziz Alsugair Ahmad Al Muhaideb Mohammed Al Qahtani |
| author_facet | Moheieldin Abouzied Ahmed Fathala Abdulaziz Alsugair Ahmad Al Muhaideb Mohammed Al Qahtani |
| author_sort | Moheieldin Abouzied |
| collection | DOAJ |
| description | Fluorodeoxyglucose (FDG)-positron emission tomography-computed tomography (PET-CT) has been playing a pivotal role in tumor imaging for the past 20 years. Head and neck (HN) cancers are a good example that can illustrate such unique role of FDG imaging contributing to the patient's management. In this review article, we will describe the normal physiological distribution of FDG within HN structures focusing on its limitations and pitfalls. In addition, we will be also describing its role in the initial staging and restaging of the disease, particularly with regard to therapy response assessment. Furthermore, its role in the evaluation of patients with malignant cervical adenopathy from an unknown primary will be described. In 2016, the Royal College of Radiologists in its third edition published evidence-based guidelines for PET-CT use in HN cancer emphasizing its rule in all these clinical scenarios that are being described in this review. Finally, we will be highlighting future directions in the field of molecular imaging of HN tumors with a special emphasis on the new PET tracers. |
| format | Article |
| id | doaj-art-d547ab357ab54aeb9c8dfd1af9202df9 |
| institution | Kabale University |
| issn | 1450-1147 1607-3312 |
| language | English |
| publishDate | 2017-10-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | World Journal of Nuclear Medicine |
| spelling | doaj-art-d547ab357ab54aeb9c8dfd1af9202df92025-08-20T03:48:36ZengThieme Medical and Scientific Publishers Pvt. Ltd.World Journal of Nuclear Medicine1450-11471607-33122017-10-01160425726510.4103/wjnm.WJNM_40_17Role of fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of head and neck carcinomaMoheieldin Abouzied0Ahmed Fathala1Abdulaziz Alsugair2Ahmad Al Muhaideb3Mohammed Al Qahtani4Department of Radiology, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaDepartment of Radiology, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaDepartment of Radiology, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaDepartment of Radiology, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaDepartment of Cyclotron and Radiopharmaceuticals, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaFluorodeoxyglucose (FDG)-positron emission tomography-computed tomography (PET-CT) has been playing a pivotal role in tumor imaging for the past 20 years. Head and neck (HN) cancers are a good example that can illustrate such unique role of FDG imaging contributing to the patient's management. In this review article, we will describe the normal physiological distribution of FDG within HN structures focusing on its limitations and pitfalls. In addition, we will be also describing its role in the initial staging and restaging of the disease, particularly with regard to therapy response assessment. Furthermore, its role in the evaluation of patients with malignant cervical adenopathy from an unknown primary will be described. In 2016, the Royal College of Radiologists in its third edition published evidence-based guidelines for PET-CT use in HN cancer emphasizing its rule in all these clinical scenarios that are being described in this review. Finally, we will be highlighting future directions in the field of molecular imaging of HN tumors with a special emphasis on the new PET tracers.http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_40_17assessment of response to therapyfluorodeoxyglucose-positron emission tomography/computed tomographyhead and neck cancerinitial stagingrestaging |
| spellingShingle | Moheieldin Abouzied Ahmed Fathala Abdulaziz Alsugair Ahmad Al Muhaideb Mohammed Al Qahtani Role of fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of head and neck carcinoma World Journal of Nuclear Medicine assessment of response to therapy fluorodeoxyglucose-positron emission tomography/computed tomography head and neck cancer initial staging restaging |
| title | Role of fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of head and neck carcinoma |
| title_full | Role of fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of head and neck carcinoma |
| title_fullStr | Role of fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of head and neck carcinoma |
| title_full_unstemmed | Role of fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of head and neck carcinoma |
| title_short | Role of fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of head and neck carcinoma |
| title_sort | role of fluorodeoxyglucose positron emission tomography computed tomography in the evaluation of head and neck carcinoma |
| topic | assessment of response to therapy fluorodeoxyglucose-positron emission tomography/computed tomography head and neck cancer initial staging restaging |
| url | http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_40_17 |
| work_keys_str_mv | AT moheieldinabouzied roleoffluorodeoxyglucosepositronemissiontomographycomputedtomographyintheevaluationofheadandneckcarcinoma AT ahmedfathala roleoffluorodeoxyglucosepositronemissiontomographycomputedtomographyintheevaluationofheadandneckcarcinoma AT abdulazizalsugair roleoffluorodeoxyglucosepositronemissiontomographycomputedtomographyintheevaluationofheadandneckcarcinoma AT ahmadalmuhaideb roleoffluorodeoxyglucosepositronemissiontomographycomputedtomographyintheevaluationofheadandneckcarcinoma AT mohammedalqahtani roleoffluorodeoxyglucosepositronemissiontomographycomputedtomographyintheevaluationofheadandneckcarcinoma |